Losartan Potassium Tablet, Film Coated
Product Images NDC 72205-143

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 72205-143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Losartan-100mg-1000s-cntr (Losartan 100mg 1000s Cntr)

Label for Losartan Potassium Tablets, USP 100 mg by Novadoz Pharmaceuticals LLC. The label indicates 1000 film-coated tablets in a bulk package, not intended for dispensing. Manufacturer is MSN Laboratories Private Limited, India. Storage instructions specify controlled room temperature and protection from light.*

FDA Label Image

Losartan-100mg-30s-cntr (Losartan 100mg 30s Cntr)

Losartan Potassium Tablets, USP 100 mg film-coated tablets label showing a package of 30 tablets. The label includes NDC 72205-143-30, distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ, with manufacturing by MSN Laboratories Private Limited, India. The label also provides storage instructions and dosage reference to package insert.*

FDA Label Image

Losartan-100mg-90s-cntr (Losartan 100mg 90s Cntr)

Label for Losartan Potassium Tablets, USP 100 mg film-coated tablets. Contains 90 tablets per bottle. Manufactured by MSN Laboratories Private Limited, India, and distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. Includes storage instructions to keep container tightly closed and protect from light, with usual dosage referenced to the package insert.*

FDA Label Image

Losartan-25mg-1000s-cntr (Losartan 25mg 1000s Cntr)

Label for Losartan Potassium Tablets, USP 25 mg film-coated tablets in a bulk package of 1000 tablets. The label states it is Rx only, includes storage instructions, manufacturer (MSN Laboratories Private Limited, India), and distributor (Novadoz Pharmaceuticals LLC). The label also features a barcode and contact information for Novadoz.*

FDA Label Image

Losartan-25mg-90s-cntr (Losartan 25mg 90s Cntr)

Losartan Potassium Tablets USP 25 mg film-coated tablets, labeled for oral use, with a package size of 90 tablets. The label includes the NDC number 72205-141-90 and states the product is Rx only. Manufactured by MSN Laboratories Private Limited and distributed by Novadoz Pharmaceuticals LLC. Storage and dosage information is also provided on the label.*

FDA Label Image

Losartan-50mg-1000s-cntr (Losartan 50mg 1000s Cntr)

Losartan Potassium Tablets, USP 50 mg film-coated tablets in a bulk package of 1000 tablets. The label includes storage instructions, manufacturer (MSN Laboratories Private Limited, India), and distributor (Novadoz Pharmaceuticals LLC, Piscataway, NJ). The label features NDC 72205-142-99 and a barcode for scanning.*

FDA Label Image

Losartan-50mg-30s-cntr (Losartan 50mg 30s Cntr)

Label for Losartan Potassium Tablets USP 50 mg, film-coated oral tablets. The package contains 30 tablets. Distributed by Novadoz Pharmaceuticals LLC. The label includes storage instructions and manufacturer details for MSN Laboratories Private Limited, India. It features a barcode and NDC number 72205-142-30.*

FDA Label Image

Losartan-50mg-90s-cntr (Losartan 50mg 90s Cntr)

Losartan Potassium Tablets USP 50 mg film-coated tablets label showing 90 tablet count. Label includes NDC 72205-142-90, manufacturer MSN Laboratories Private Limited, and distributor Novadoz Pharmaceuticals LLC. The label features key storage instructions and a barcode.*

FDA Label Image

Fig-1 (Losartan Fig 1)

A line graph comparing the percentage of patients with a primary endpoint over study months for Losartan potassium and Atenolol. The graph shows cumulative patient percentages on the y-axis and study duration in months on the x-axis, with an adjusted risk reduction of 13% (p=0.021) noted.*

FDA Label Image

Fig-2 (Losartan Fig 2)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over time between those treated with Losartan potassium and Atenolol. The X-axis represents study months up to 66, and the Y-axis shows the percentage of patients affected. The graph indicates a lower stroke percentage for Losartan potassium, with an adjusted risk reduction of 25% (p=0.001).*

FDA Label Image

Fig-3 (Losartan Fig 3)

A forest plot graph comparing the event rates and hazard ratios for Losartan potassium versus Atenolol across various patient subgroups. The graph includes primary composite outcomes and stroke (fatal/non-fatal) outcomes, stratified by age, gender, race, ISH, diabetes, and history of cardiovascular disease. Data points indicate hazard ratios with 95% confidence intervals and favor either Losartan potassium or Atenolol.*

FDA Label Image

Fig-4 (Losartan Fig 4)

A line graph showing the percentage of patients with an event over 48 months for Losartan potassium and placebo groups. The graph depicts risk reduction with Losartan potassium compared to placebo, with statistical data including a risk reduction of 16.1% and p-value of 0.022.*

FDA Label Image

Str (Losartan Structure)

Chemical structure of losartan potassium showing its molecular arrangement with potassium ion (K+).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.